Programmed Cell Death Protein-1 (PD-1) represents endogenous mechanisms of negative immunoregulation. While the modulation of effector functions has been the major focus of PD-1 research, quick PD-1 ...

A new study helps explain why having ApoE4—the gene variant most closely linked to Alzheimer's disease—increases the risk of neurodegeneration and white matter damage. Researchers at Weill ...

Method Man doesn’t just want your admiration. The Wu-Tang Clan rapper recently sat down with Tamron Hall who asked him about being seen as a “sex symbol.” She pulled the phrasing from his ...

doctors discovered it was mysteriously missing a surface molecule found on all other known red blood cells at the time. After 50 years, this strange molecular absence finally led researchers from the ...

Tim Burton offered up an explanation for his casting choices after a number of his movies were called out for featuring predominantly white actors. Director and animator Burton has established himself ...

For her fifth feature as director, Angelina Jolie has gone so far back to basics that Without Blood could quite easily be her debut. That isn’t a criticism, rather an observation about how hard ...

Tesla has announced that it produced its 100 millionth 4680 battery cell. Here’s what it means for its production growth. The 4680 battery cell is a new format, 46mm x 80mm, enabled by a few new ...

In 1972, a pregnant woman had her blood taken, and doctors noticed that her red blood cells seemed to lack a surface marker, known as an antigen, that everyone else seemed to have. No one knew why.

Engineered immune cells called CAR Ts that can seek out and destroy B cells have transformed the treatment of some blood cancers, and are raising hopes for possible cures for autoimmune diseases.

September 24, 2024, Sasquatch Books. Published with permission. The red of a blood moon is the perfect example of how two separate bodies can have a drastic yet temporary effect on one another.

When assessed by histology, the benefit derived from relatlimab plus nivolumab and chemotherapy compared with nivolumab plus chemotherapy was further enhanced in patients with nonsquamous cell ...